Skip to main content
Clinical Trials/NCT06753552
NCT06753552Not yet recruitingNot Applicable

Combined Effect of Underwater Ultrasound and Custom-made Foot Orthotics in Patients With Rheumatoid Arthritis: A Randomised Controlled Trial

Kirsehir Ahi Evran Universitesi1 site in 1 country75 target enrollmentStarted: February 25, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
75
Locations
1
Primary Endpoint
DAS-28

Study Overview

Brief Summary

This randomised controlled trial aims to investigate the effects of underwater ultrasound therapy and customised foot insoles in RA patients. The study evaluates the effects of the combined use of these two methods on pain, functional status and quality of life. The research aims to contribute to current treatment approaches and to demonstrate the effectiveness of innovative methods to improve the quality of life of RA patients.

Detailed Description

Rheumatoid arthritis (RA) is a chronic inflammatory disease that can cause pain, swelling, limitation of movement and deformities in the joints (Cabrera-Sánchez et al. 2024)(Cabrera-Sánchez et al. 2024). Foot and ankle involvement is quite common in RA patients and this may adversely affect the daily living activities of patients. In addition to pharmacological approaches, physical therapy methods and the use of biomechanical supports are also important in the treatment of RA.

Ultrasound is a physical therapy method used to reduce pain and inflammation and accelerate tissue healing (Király et al. 2021). Underwater ultrasound applications may be more effective in superficial areas and may reduce the risk of damage to sensitive tissues around the joint. On the other hand, customised foot insoles (orthotics) are frequently used to correct foot deformities, eliminate biomechanical imbalances and reduce pain (Gaino et al. 2021).

This randomised controlled trial aims to examine the effects of underwater ultrasound therapy and customised foot insoles in RA patients. The study evaluates the effects of the combined use of these two methods on pain, functional status and quality of life. The research aims to contribute to current treatment approaches and to demonstrate the effectiveness of innovative methods to improve the quality of life of RA patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • - ACR/EULAR 2010 diagnostic criteria with foot involvement and having a disease duration of less than two years were enrolled in the study over a period of three months.
  • with foot involvement diagnosed by a rheumatologist.

Exclusion Criteria

  • - Degenerative diseases and anatomical abnormalities were excluded
  • if they presented in an acute symptomatic flare or they needed to use walking assistance
  • neurological problems, malignant process, cognitive deterioration, pregnancy, previous foot surgery and the presence of a foot wound

Outcomes

Primary Outcomes

DAS-28

Time Frame: 4 weeks

Measures disease activity by evaluating 28 joints for swelling and tenderness.

Manchester-Oxford Foot Questionnaire (MOXFQ)

Time Frame: 2 weeks

Health Assessment Questionnaire [HAQ]

Time Frame: 2 weeks

Berg Balance Test

Time Frame: 4 weeks

Useful for the measurement of the risk of falls and for demonstrating the progress patients in exercise programs oriented to the improve of balance for falls prevention.

Secondary Outcomes

  • X-Ray(4 weeks)
  • Ankle Girth Measurement(4 weeeks)
  • Timed Up and Go Test(4 weeks)
  • Quebec User Evaluation of Satisfaction:(4 weeks)

Investigators

Sponsor
Kirsehir Ahi Evran Universitesi
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ömer Faruk ÖZÇELEP

Researcher

Kirsehir Ahi Evran Universitesi

Study Sites (1)

Loading locations...

Similar Trials